Wave Life Sciences Ltd. (WVE) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Wave Life Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.076 I will now turn the call over to Kate Roush, Vice President of Corporate Affairs and 00:00:04.076 -- 00:00:06.476 Investor Relations. 00:00:06.959 -- 00:00:09.743 Thank you, Operator, and good morning to everyone on the call. 00:00:09.743 -- 00:00:13.327 Earlier this morning, we issued a press release outlining our third quarter 2025 earnings 00:00:13.327 -- 00:00:16.250 update. Joining me today with prepared remarks are Dr. 00:00:16.250 -- 00:00:20.916 Paul Bono, President and Chief Executive Officer, and Kyle Moran, Chief Financial Officer. 00:00:20.916 -- 00:00:23.696 Dr. Chris Wright, Chief Medical Officer. Dr. 00:00:23.696 -- 00:00:26.339 Eric Engelson, Chief Scientific Officer, and Dr. 00:00:26.339 -- 00:00:29.604 Chandra Varghese, Chief Technology Officer, will be available for questions following 00:00:29.604 -- 00:00:33.410 the prepared remarks. The press release issued this morning is available in the investor 00:00:33.410 -- 00:00:36.511 section of our website, www.wavelifesciences.com. 00:00:37.956 -- 00:00:40.940 Before we begin, I would like to remind you that discussions during this conference call 00:00:40.940 -- 00:00:44.466 will include forward-looking statements. These statements are subject to several risks 00:00:44.466 -- 00:00:47.931 and uncertainties that could cause their actual results to differ materially from those 00:00:47.931 -- 00:00:50.032 described in these forward-looking statements. 00:00:50.032 -- 00:00:53.297 The factors that could cause our actual results to differ are discussed in the press 00:00:53.297 -- 00:00:55.880 release issued today and in our SEC filings. 00:00:55.880 -- 00:00:59.225 We undertake no obligation to update or revise any forward-looking statement for any 00:00:59.225 -- 00:...